Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and time-to-remission in males with COVID-19: a randomized, double-blind, placebo-controlled interventional trial (EAT-DUTA AndroCoV trial–biochemical) - Cadegiani, F A; McCoy, J; Wambier, C G (Cureus, 2021)
et al.